| Trial ID: | L5388 |
| Source ID: | NCT00567775
|
| Associated Drug: |
Human Insulin
|
| Title: |
Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: human insulin|DRUG: inhaled human insulin
|
| Outcome Measures: |
Primary: Area under the serum insulin curve, from 0 to 5 hours post-dosing | Secondary: Maximum serum insulin concentration, in the interval from 0 to 5 hours post-dosing|Time to maximum serum insulin concentration, in the interval from 0 to 5 hours post-dosing
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
PHASE2
|
| Enrollment: |
27
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2002-10-21
|
| Completion Date: |
2002-11-20
|
| Results First Posted: |
|
| Last Update Posted: |
2017-03-01
|
| Locations: |
Novo Nordisk Investigational Site, Glostrup, 2600, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00567775
|
